Study of TYK-00540 Tablets in Patients With Advanced Solid Tumors

Clinical trial NCT06950086 · RECRUITING

Trial details

NCT number: NCT06950086
Sponsor: TYK Medicines, Inc
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HR-positive, HER2-negative Advanced Breast Cancer

Start date: 2024-01-02
Primary completion: 2026-09-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.